160 SECOND STREET, CAMBRIDGE, MA
Market cap: $1.9M (8/06/2024)
Price: $0.07
Completes Transactions Under Amended Acquisition Agreement
Vaccines Provides an Update on its Restructuring Proceedings and Announces Partial Revocation Order from the British Columbia Securities Commission
Bankruptcy or Receivership, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events
Initiates Restructuring Proceedings Under CCAA to Implement a Review of its Strategic Alternatives
Shareholder votes, Other Events
Announces New Tumor Response Data from Ongoing Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma Patients
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Earnings Release
Q1
FY 2023
Notice of Late Filing for Annual Report
Q3
Q2
FY 2022
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(5)
Notice of Exempt Offering of Securities
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Notification Filed by a National Security Exchange
Amended Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Post-Effective Amendment to Registration Statement
S-8 POS
Correspondence